Product Code: ETC063827 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Indonesia Barbiturate Drugs market is estimated to register a CAGR of 4.4% during theperiod (2021-2027). The barbiturates are sedative or hypnotic drugs that have been used for centuries as a therapeutic agent for various medical conditions such as anxiety and insomnia. These drugs are known to potentiate the effects of alcohol and other central nervous system depressants while they can also cause habituation if taken in excessive amounts. In recent years however due to their potential side effects including physical dependence and severe withdrawal symptoms upon cessation of administration barbiturates have been replaced with safer benzodiazepines like Valium or Xanax for treating anxiety or sleeping disorders. As per WHO statistics from 2018 an estimated 10 million Indonesias suffered from depression disorder; thus representing 28% of the total population aged 18-59 years in Indonesia suffering from mental health disorder at some point in their life time indicating that there is an increasing demand for antianxiety/antidepressant medications which may fuel theof this market over the next few years.
Increasing prevalence rate of mental health issues across Indonesia coupled with rising awareness among people regarding mental illnesses will drive theprospects for this market over the coming years. Additionally rapid urbanization along with changing lifestyle has further led to increased stress levels leading more people towards depression hence fueling need for medication such as antidepressants which will spur product demand duringtimeline. Moreover presence of well developed healthcare infrastructure comprising both public private hospitals adds up to growing adoption rate making it easier fro patients avail these treatments without any difficulties further propelling overall.
Despite numerous benefits associated with these products major challenge faced by players operating in this space remains high cost involved due to complex manufacturing process involving certain active ingredients resulting into expensive end user prices thereby limiting access availability especially amongst low income patients hampering total business landscape.
Key Players Operating In This Space Include:Boehringer Ingelheim GmbH; Pfizer Inc.; Novartis AG; GlaxoSmithKline Plc.; AstraZeneca PLC ; Sanofi Aventis SRL ; Abbott Laboratories Ltd.; Merck KGaA; Ranbaxy Pharmaceuticals Ltd.; Bayer Healthcare AG.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Barbiturate Drugs Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Barbiturate Drugs Market Revenues & Volume, 2020 & 2027F |
3.3 Indonesia Barbiturate Drugs Market - Industry Life Cycle |
3.4 Indonesia Barbiturate Drugs Market - Porter's Five Forces |
3.5 Indonesia Barbiturate Drugs Market Revenues & Volume Share, By Types, 2020 & 2027F |
3.6 Indonesia Barbiturate Drugs Market Revenues & Volume Share, By Application, 2020 & 2027F |
4 Indonesia Barbiturate Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Barbiturate Drugs Market Trends |
6 Indonesia Barbiturate Drugs Market, By Types |
6.1 Indonesia Barbiturate Drugs Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Barbiturate Drugs Market Revenues & Volume, By Types, 2018 - 2027F |
6.1.3 Indonesia Barbiturate Drugs Market Revenues & Volume, By Ultra-Short Acting Barbiturate, 2018 - 2027F |
6.1.4 Indonesia Barbiturate Drugs Market Revenues & Volume, By Short-Acting Barbiturate, 2018 - 2027F |
6.1.5 Indonesia Barbiturate Drugs Market Revenues & Volume, By Long-Acting Barbiturate, 2018 - 2027F |
6.1.6 Indonesia Barbiturate Drugs Market Revenues & Volume, By Combination Drugs, 2018 - 2027F |
6.2 Indonesia Barbiturate Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Barbiturate Drugs Market Revenues & Volume, By Hospital Pharmacies, 2018 - 2027F |
6.2.3 Indonesia Barbiturate Drugs Market Revenues & Volume, By Retail Pharmacies, 2018 - 2027F |
6.2.4 Indonesia Barbiturate Drugs Market Revenues & Volume, By Online Pharmacies, 2018 - 2027F |
7 Indonesia Barbiturate Drugs Market Import-Export Trade Statistics |
7.1 Indonesia Barbiturate Drugs Market Export to Major Countries |
7.2 Indonesia Barbiturate Drugs Market Imports from Major Countries |
8 Indonesia Barbiturate Drugs Market Key Performance Indicators |
9 Indonesia Barbiturate Drugs Market - Opportunity Assessment |
9.1 Indonesia Barbiturate Drugs Market Opportunity Assessment, By Types, 2020 & 2027F |
9.2 Indonesia Barbiturate Drugs Market Opportunity Assessment, By Application, 2020 & 2027F |
10 Indonesia Barbiturate Drugs Market - Competitive Landscape |
10.1 Indonesia Barbiturate Drugs Market Revenue Share, By Companies, 2020 |
10.2 Indonesia Barbiturate Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |